Can a special diet help fight uterine cancer? researchers test Low-Carb approach
NCT ID NCT03285152
Summary
This study is testing whether a very low-carbohydrate (ketogenic) diet is safe and tolerable for overweight or obese patients newly diagnosed with endometrial (uterine) cancer before they have surgery. Researchers want to see if patients can stick to the diet and what effects it has on the body's metabolism and tumor tissue. The goal is to gather information to see if this dietary approach should be studied further as a possible part of cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Basking Ridge (Consent and Follow up)
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen (Consent and Follow up)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth (Consent and follow-up only)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (Consent and Follow-up)
Rockville Centre, New York, 11570, United States
-
Memorial Sloan Kettering Westchester (Consent & Follow Up)
Harrison, New York, 10604, United States
-
New York Weill Cornell Cancer Center at Cornell University
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.